Lv1
4 积分 2022-11-07 加入
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
1个月前
已完结
The complex language of chromatin regulation during transcription
1个月前
已完结
Pharmacological targeting of the cancer epigenome
1个月前
已完结
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer
1个月前
已完结
Targeting EZH2 in cancer
1个月前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
3个月前
已完结
The Werner syndrome RECQ helicase as a therapeutic target: new insights
6个月前
已完结
Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties
6个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
9个月前
已完结
MEK inhibitors in oncology: a patent review and update (2016 - present)
10个月前
已完结
皖公网安备34019202002308
